VASOACTIVE INTESTINAL PEPTIDE-MEDIATED SUPPRESSION OF APOPTOSIS IN THE OVARY - POTENTIAL MECHANISMS OF ACTION AND EVIDENCE OF A CONSERVED ANTIATRETOGENIC ROLE THROUGH EVOLUTION
Ja. Flaws et al., VASOACTIVE INTESTINAL PEPTIDE-MEDIATED SUPPRESSION OF APOPTOSIS IN THE OVARY - POTENTIAL MECHANISMS OF ACTION AND EVIDENCE OF A CONSERVED ANTIATRETOGENIC ROLE THROUGH EVOLUTION, Endocrinology, 136(10), 1995, pp. 4351-4359
Vasoactive intestinal peptide (VIP)-containing nerve fibers are presen
t in ovarian follicles at all stages of development, and VIP, acting p
rimarily via the cAMP pathway, has been reported to modulate many aspe
cts of granulosa cell function. Herein we examined the effects of VIP
and its potential mechanisms of action on apoptosis in antral follicle
s isolated from ovaries of gonadotropin-primed immature rats and incub
ated in vitro under serum-free conditions. Additionally, the effects o
f VIP on apoptosis in isolated avian granulosa cells incubated in vitr
o were used as a comparative model system to determine whether the abi
lity of VIP to modulate apoptosis in the ovary has been conserved thro
ugh evolution. Genomic DNA extracted from incubated rat antral follicl
es exhibited extensive levels of internucleosomal DNA cleavage charact
eristic of cell death via apoptosis. Treatment of follicles with VIP (
1-1000 nM) caused a dose-dependent reduction in the extent of apoptoti
c DNA breakdown, with a maximal effect achieved with 100 nM VIP. Provi
sion of the adenylyl cyclase activator, forskolin (10 mu M), mimicked
the inhibitory effect of VIP on apoptosis and concomitantly increased
intrafollicular cAMP accumulation, suggesting a role for the cAMP path
way in mediating the immediate actions of VIP on follicular cell survi
val, Moreover, treatment of rat antral follicles with insulin-like gro
wth factor-binding protein 3 (3 mu g/ml) partially antagonized the abi
lity of VIP (100 nM) to suppress apoptosis, suggesting involvement of
endogenous insulin-like growth factor I in mediating the downstream ac
tions of VIP in incubated rat antral follicles. To further confirm tha
t VIP and activation of the cAMP pathway prevented atresia, individual
rat antral follicles incubated for 24 h in the absence or presence of
VIP (100 nM) or forskolin (10 mu M) were fixed, embedded, and section
ed for morphological analysis. Follicles fixed immediately after isola
tion from equine CG-primed rat ovaries were classified as morphologica
lly healthy, consistent with the absence of biochemical evidence for a
poptosis (e.g. oligonucleosomes) in this pool of follicles. Follicles
incubated for 24 h in the absence of tropic support displayed extensiv
e granulosa cell pyknosis and disorganization characteristic of follic
les at a moderate stage of atresia. Inclusion of VIP or forskolin main
tained the morphological health status of incubated follicles at that
resembling healthy follicles fixed immediately after isolation from ov
aries of equine CG-primed rats. Lastly, extensive levels of internucle
osomal DNA cleavage were also detected in avian granulosa cells incuba
ted for 6 h under serum-free conditions. Moreover, the extent of apopt
otic DNA breakdown was significantly reduced by treatment with VIP (10
00 nM) or the membrane-permeable cAMP analog, 8-bromo-cAMP (1 mM) sugg
esting that the role of VIP in promoting follicular cell survival has
been conserved through evolution. From these data, we propose that int
rafollicular neuropeptides such as VIP can act to prevent the atresia
of developing follicles in the absence of gonadotropins. Activation of
the cAMP-protein kinase A pathway may function as one mechanism by wh
ich VIP suppresses apoptosis in granulosa cells, and the antiatretogen
ic actions of VIP in the rat follicle may also be mediated at least in
part via increased intrafollicular levels or the bioactivity of insul
in-like growth factor I.